Critics question FDA, U.S. Customs handling of Ranbaxy case (The Star-Ledger)
For two and a half years, the Food and Drug Administration collected evidence that Ranbaxy Laboratories, India's largest generic drugmaker, may have lied about the quality of medicines and chemicals it sent to the U.S.